OLOPATADINE Labatec gtt opht fl 5 ml
7680686050013
CH-68605
S01GX09
1 / 3
google
Details
- GTIN
- 7680686050013
- Pharmacode
- -
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Olopatadine Labatec 1mg/ml, Collyre en solution
Augentropfen
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
olopatadinum
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
olopatadini hydrochloridum
|
- | Substance | WIZUS |
|
benzalkonii chloridum
|
0.1 MG | Substance | HBESI |
|
natrii chloridum
|
- | Substance | HNIDK |
|
dinatrii phosphas
|
- | Substance | HNIDK |
|
phosphas
|
3.35 MG | Substance | HBESI |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 68605
- Drug name
- Olopatadine Labatec 1mg/ml, Collyre en solution
- Galenic form
- AUL
- ATC Code
- S01GX09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 16/12/2022
- Authorization expiration date
- 15/12/2027
- IT number
- 11.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OLOPATADINE Labatec gtt opht fl 5 ml
- Description (DE)
- OLOPATADINE Labatec Gtt Opht Fl 5 ml
- Market launch
- 16/12/2022
- Narcotic (BTM)
- No